Ad5Ag85A

BIOLOGICAL2 trials

Sponsors

McMaster University

Conditions

Tuberculosis

Phase 1

Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine

TerminatedNCT00800670

McMaster UniversityTuberculosis

Start: 2009-06-30End: 2013-07-31Updated: 2017-09-08

Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol

CompletedNCT02337270

McMaster UniversityTuberculosis

Start: 2017-09-05End: 2021-09-07Updated: 2021-11-01

Related Papers

Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans

JCI Insight2022-01-0688 citations